Amedica (AMDA) Reaches New 52-Week Low at $2.77
Amedica Co. (NASDAQ:AMDA) shares reached a new 52-week low on Tuesday . The stock traded as low as $2.77 and last traded at $2.78, with a volume of 32431 shares. The stock had previously closed at $3.02.
A number of analysts have weighed in on AMDA shares. Ladenburg Thalmann Financial Services lowered Amedica from a “buy” rating to a “neutral” rating in a research note on Monday, November 27th. ValuEngine upgraded Amedica from a “sell” rating to a “hold” rating in a research note on Friday, November 10th. Finally, Maxim Group restated a “hold” rating on shares of Amedica in a research note on Wednesday, January 24th.
The firm has a market capitalization of $7.95, a PE ratio of -1.36 and a beta of -1.82.
A hedge fund recently raised its stake in Amedica stock. Vanguard Group Inc. boosted its stake in shares of Amedica Co. (NASDAQ:AMDA) by 7.1% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 595,866 shares of the medical equipment provider’s stock after purchasing an additional 39,603 shares during the quarter. Vanguard Group Inc. owned approximately 2.26% of Amedica worth $226,000 as of its most recent SEC filing. Institutional investors own 61.76% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Amedica (AMDA) Reaches New 52-Week Low at $2.77” was published by Daily Political and is the sole property of of Daily Political. If you are viewing this report on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark legislation. The legal version of this report can be accessed at https://www.dailypolitical.com/2018/02/08/amedica-amda-reaches-new-52-week-low-at-2-77.html.
Amedica Corporation is a commercial biomaterial company. The Company is a vertically integrated silicon nitride orthopedic medical device manufacturer. It is focused on using its silicon nitride ceramic technology platform to develop, manufacture and sell a range of medical devices. It is also engaged in developing wear- and corrosion-resistant implant components for hip and knee arthroplasty.
Receive News & Ratings for Amedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedica and related companies with MarketBeat.com's FREE daily email newsletter.